Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients (Retraction of vol 37, pg 154, 2014)

Derosa Giuseppe; Cicero Arrigo F. G.; Carbone Anna; Querci Fabrizio; Fogari Elena; DAngelo Angela; Maffioli Pamela

首页> 外文期刊>Inflammation >Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients (Retraction of vol 37, pg 154, 2014)

【24h】

Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients (Retraction of vol 37, pg 154, 2014)

机译：与单一疗法对高血压患者炎症和代谢指标的单一疗法相比，Sartan +钙拮抗药协会的不同方面（第37卷撤消，第154页，2014年）

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Inflammation》 |2016年第1期|共1页
作者
Derosa Giuseppe; Cicero Arrigo F. G.; Carbone Anna; Querci Fabrizio; Fogari Elena; DAngelo Angela; Maffioli Pamela;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类基础医学;
关键词

相似文献

外文文献

1. Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients (Retraction of vol 37, pg 154, 2014) [J] . Derosa Giuseppe, Cicero Arrigo F. G., Carbone Anna, Inflammation . 2016,第1期

机译：与单一疗法对高血压患者炎症和代谢指标的单一疗法相比，Sartan +钙拮抗药协会的不同方面（第37卷撤消，第154页，2014年）
2. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160). [J] . Ogawa H, Kim Mitsuyama S, Jinnouchi T Hypertension research: Official journal of the Japanese Society of Hypertension . 2009,第7期

机译：OlmeSartan和钙拮抗剂随机研究（OSCAR）的基本原理，设计和患者基线特征：一项针对日本老年人的大剂量血管紧张素II受体阻滞剂（ARB）单药治疗和ARB与钙通道阻滞剂联合治疗之间心血管事件发生率的比较研究高危高血压患者（ClinicalTrials。gov No. NCT00134160）。
3. Long-term use of angiotensin II receptor antagonists and calcium-channel antagonists in Algerian hypertensive patients: Effects on metabolic and oxidative parameters [J] . El Hassar Chafika, Merzouk Hafida, Merzouk Sid Ahmed, Free Radical Biology and Medicine: The Official Journal of the Oxygen Society . 2015,第Null期

机译：阿尔及利亚高血压患者长期使用血管紧张素II受体拮抗剂和钙通道拮抗剂：对代谢和氧化参数的影响
4. Larger Blood Pressure Reduction by Fixed-Dose Compared to Free Dose Combination Therapy of ACE Inhibitor and Calcium Antagonist in Hypertensive Patients [O] . Valeria Visco, Rosa Finelli, Antonietta Valeria Pascale, 2017

机译：与ACE抑制剂和钙拮抗剂的自由剂量联合治疗相比固定剂量的血压降低更大
5. Retraction Note to: Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients [O] . Giuseppe Derosa, Arrigo F. G. Cicero, Anna Carbone, 2015

机译：收缩注意：与高血压患者炎症和代谢参数的单一治疗相比，沙坦+钙拮抗剂关联的不同方面

Different Aspects of Sartan + Calcium Antagonist Association Compared to the Single Therapy on Inflammation and Metabolic Parameters in Hypertensive Patients (Retraction of vol 37, pg 154, 2014)

著录项

引文网络

相似文献

相关主题

期刊订阅